Jan 30, 2023, 10:27 AM by

Jan 30, 2023, 10:27 AM by

A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry.

Jan 30, 2023, 10:26 AM by

Jan 30, 2023, 10:22 AM by

Jan 30, 2023, 10:21 AM by

Jan 30, 2023, 10:21 AM by

Jan 30, 2023, 10:21 AM by

Jan 30, 2023, 10:11 AM by

About Huateng Pharma Huateng Pharma is a leading and professional manufacturer which can provide APIs, pharmaceutical intermediates, PEG derivatives, biochemical reagents, Vitamin D Derivatives and so on. We have established a 5000 square meters R&D center and have our own manufacturing site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

Jan 27, 2023, 09:49 AM by

Jan 27, 2023, 01:00 AM by User Not Found

Bio-IT World | Information directly from DNA to understand RNA's and human proteins' downstream structure describes how our cells function in clear linguistic terms. Today, large language models demonstrate remarkable abilities to interpret, translate, summarize, and generate human languages. Now, we are finally generating the amount of data required to train such models in the language of biology.

Jan 26, 2023, 09:50 AM by

Jan 26, 2023, 09:50 AM by

Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial

Jan 26, 2023, 01:00 AM by User Not Found

Bio-IT World | A Salmonella-based bactofection platform to deliver RNA payloads to treat cancer patients; tRNA therapeutics capable of overcoming genetic errors to treat genetic diseases and cancer; the Jackson Laboratory enters an expansive and exclusive intellectual property licensing agreement across six areas of human health; and more.

Jan 25, 2023, 09:32 AM by

Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference

Jan 25, 2023, 09:32 AM by

Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials

Jan 25, 2023, 09:31 AM by

Kyruus today announced that integrated healthcare delivery system, Bellin Health, recently selected Kyruus to support a new digital patient access experience on its website.

Jan 25, 2023, 09:24 AM by

Recent accolades honoring the company’s technology and workplace reflect its growing industry impact

Jan 24, 2023, 09:20 AM by User Not Found

Bio-IT World | In the latest episode of Trends from the Trenches podcast, host Stan Gloss of BioTeam sits down with Chris Gibson, co-founder and CEO of Recursion, to talk about Recursion’s mission to decode biology, radically improve lives, and set big goals to innovate across every stage of drug discovery.

Jan 24, 2023, 01:00 AM by User Not Found

Bio-IT World | Funding for new therapeutic targets for a proprietary genetic medicines pipeline fueled by an automated discovery engine and versatile gene-editing toolbox, an in vivo engineered cell therapy platform for immuno-oncology genomic medicines, advanced therapeutic nucleic acids manufacturing, and more.

Jan 20, 2023, 09:37 AM by

AVIA just announced the launch of AVIA Marketplace, a vendor selection platform available for free. It provides a one-stop shop for hospital and health systems executives to research and select digital health solutions for their transformation journey.